BCRX
BioCryst Pharmaceuticals Inc
NASDAQ: BCRX · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$8.99
+1.47% today
Updated 2026-04-29
Market cap
$2.28B
P/E ratio
7.43
P/S ratio
2.61x
EPS (TTM)
$1.21
Dividend yield
—
52W range
$6 – $11
Volume
5.5M
BioCryst Pharmaceuticals Inc (BCRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.21M | $71.24M | $56.56M | $74.59M | $63.50M | $19.64M | $26.29M | $17.33M | $13.61M | $48.26M | $26.35M | $25.19M | $20.65M | $48.84M | $17.81M | $157.17M | $270.83M | $331.41M | $450.71M | $874.84M |
| Revenue growth (YoY) | — | +1046.8% | -20.6% | +31.9% | -14.9% | -69.1% | +33.9% | -34.1% | -21.5% | +254.6% | -45.4% | -4.4% | -18.0% | +136.5% | -63.5% | +782.4% | +72.3% | +22.4% | +36.0% | +94.1% |
| Cost of revenue | $32.86M | $71.95M | $46.81M | $4.54M | $86000.00 | $68.19M | $132000.00 | $98000.00 | $122000.00 | $1.90M | $2.70M | $1.70M | $471000.00 | $4.10M | $1.68M | $7.26M | $6.59M | $4.66M | $12.48M | $19.07M |
| Gross profit | $6.21M | $71.24M | $56.56M | $70.05M | $63.41M | $19.64M | $26.16M | $17.23M | $13.49M | $46.36M | $23.65M | $23.48M | $20.18M | $44.73M | $16.14M | $149.91M | $264.23M | $326.75M | $438.23M | $855.76M |
| Gross margin | 100.0% | 100.0% | 100.0% | 93.9% | 99.9% | 100.0% | 99.5% | 99.4% | 99.1% | 96.1% | 89.8% | 93.2% | 97.7% | 91.6% | 90.6% | 95.4% | 97.6% | 98.6% | 97.2% | 97.8% |
| R&D | $47.08M | $94.05M | $73.33M | $72.30M | $82.47M | $56.90M | $51.46M | $42.73M | $51.80M | $72.76M | $61.01M | $66.96M | $84.89M | $107.07M | $122.96M | $208.81M | $253.30M | $216.57M | $174.64M | $166.13M |
| SG&A | $6.11M | $9.47M | $10.40M | $11.48M | $14.18M | $12.33M | $6.83M | $5.22M | $7.46M | $13.05M | $11.25M | $13.93M | $29.51M | $37.12M | $61.36M | $113.11M | $144.48M | $199.14M | $252.50M | $348.65M |
| Operating income | $-46.98M | $-32.28M | $-27.16M | $-13.74M | $-33.24M | $-49.59M | $-33.89M | $-30.72M | $-45.77M | $-39.44M | $-48.61M | $-57.41M | $-94.22M | $-99.45M | $-174.76M | $-177.72M | $-148.44M | $-103.71M | $-2.54M | $340.99M |
| Operating margin | -756.3% | -45.3% | -48.0% | -18.4% | -52.3% | -252.4% | -128.9% | -177.2% | -336.4% | -81.7% | -184.4% | -227.9% | -456.2% | -203.7% | -981.1% | -113.1% | -54.8% | -31.3% | -0.6% | 39.0% |
| EBITDA | $-42.80M | $-27.69M | $-23.11M | $-12.13M | $-30.97M | $-52.29M | $-33.79M | $-25.03M | $-40.01M | $-37.64M | $-48.17M | $-56.51M | $-90.36M | $-96.28M | $-167.56M | $-121.74M | $-143.85M | $-116.33M | $12.81M | $347.65M |
| EBITDA margin | -688.9% | -38.9% | -40.9% | -16.3% | -48.8% | -266.2% | -128.5% | -144.4% | -294.0% | -78.0% | -182.8% | -224.4% | -437.5% | -197.2% | -940.7% | -77.5% | -53.1% | -35.1% | 2.8% | 39.7% |
| EBIT | $-43.62M | $-29.06M | $-24.73M | $-13.74M | $-33.24M | $-53.17M | $-34.41M | $-25.33M | $-40.19M | $-37.82M | $-48.66M | $-57.22M | $-91.14M | $-97.00M | $-168.31M | $-122.52M | $-145.29M | $-117.99M | $11.56M | $346.26M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3.77M | $4.67M | $4.78M | $5.00M | $5.20M | $6.49M | $8.56M | $9.18M | $11.89M | $14.50M | $59.29M | $99.09M | $108.24M | $98.52M | $78.87M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-43.62M | $-29.06M | $-24.73M | $-13.45M | $-32.73M | $-56.95M | $-39.08M | $-30.11M | $-45.19M | $-43.02M | $-55.14M | $-65.78M | $-101.25M | $-108.90M | $-182.81M | $-184.06M | $-247.12M | $-226.54M | $-88.88M | $263.86M |
| Net income growth (YoY) | — | +33.4% | +14.9% | +45.6% | -143.3% | -74.0% | +31.4% | +23.0% | -50.1% | +4.8% | -28.2% | -19.3% | -53.9% | -7.6% | -67.9% | -0.7% | -34.3% | +8.3% | +60.8% | +396.9% |
| Profit margin | -702.2% | -40.8% | -43.7% | -18.0% | -51.5% | -289.9% | -148.6% | -173.7% | -332.1% | -89.1% | -209.3% | -261.2% | -490.3% | -223.0% | -1026.4% | -117.1% | -91.2% | -68.4% | -19.7% | 30.2% |